BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

710 related articles for article (PubMed ID: 20937352)

  • 1. Interleukin-17A induces cathepsin K and MMP-9 expression in osteoclasts via celecoxib-blocked prostaglandin E2 in osteoblasts.
    Zhang F; Tanaka H; Kawato T; Kitami S; Nakai K; Motohashi M; Suzuki N; Wang CL; Ochiai K; Isokawa K; Maeno M
    Biochimie; 2011 Feb; 93(2):296-305. PubMed ID: 20937352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-17A suppresses the expression of bone resorption-related proteinases and osteoclast differentiation via IL-17RA or IL-17RC receptors in RAW264.7 cells.
    Kitami S; Tanaka H; Kawato T; Tanabe N; Katono-Tani T; Zhang F; Suzuki N; Yonehara Y; Maeno M
    Biochimie; 2010 Apr; 92(4):398-404. PubMed ID: 20045440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Compressive force induces osteoclast differentiation via prostaglandin E(2) production in MC3T3-E1 cells.
    Sanuki R; Shionome C; Kuwabara A; Mitsui N; Koyama Y; Suzuki N; Zhang F; Shimizu N; Maeno M
    Connect Tissue Res; 2010 Apr; 51(2):150-8. PubMed ID: 20001844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection against titanium particle-induced osteoclastogenesis by cyclooxygenase-2 selective inhibitor.
    Geng DC; Zhu XS; Mao HQ; Meng B; Chen L; Yang HL; Xu YZ
    J Biomed Mater Res A; 2011 Dec; 99(4):516-22. PubMed ID: 21913318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Receptor activator of NF-kappaB ligand induces the expression of carbonic anhydrase II, cathepsin K, and matrix metalloproteinase-9 in osteoclast precursor RAW264.7 cells.
    Fujisaki K; Tanabe N; Suzuki N; Kawato T; Takeichi O; Tsuzukibashi O; Makimura M; Ito K; Maeno M
    Life Sci; 2007 Mar; 80(14):1311-8. PubMed ID: 17306833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteoprotegerin influences the bone resorption activity of osteoclasts.
    Fu YX; Gu JH; Zhang YR; Tong XS; Zhao HY; Yuan Y; Liu XZ; Bian JC; Liu ZP
    Int J Mol Med; 2013 Jun; 31(6):1411-7. PubMed ID: 23563320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-6 and soluble interleukin-6 receptor suppress osteoclastic differentiation by inducing PGE(2) production in chondrocytes.
    Honda K
    J Oral Sci; 2011 Mar; 53(1):87-96. PubMed ID: 21467819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nicotine affects bone resorption and suppresses the expression of cathepsin K, MMP-9 and vacuolar-type H(+)-ATPase d2 and actin organization in osteoclasts.
    Tanaka H; Tanabe N; Kawato T; Nakai K; Kariya T; Matsumoto S; Zhao N; Motohashi M; Maeno M
    PLoS One; 2013; 8(3):e59402. PubMed ID: 23555029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-17A stimulates the expression of inflammatory cytokines via celecoxib-blocked prostaglandin in MC3T3-E1 cells.
    Zhang F; Koyama Y; Sanuki R; Mitsui N; Suzuki N; Kimura A; Nakajima A; Shimizu N; Maeno M
    Arch Oral Biol; 2010 Sep; 55(9):679-88. PubMed ID: 20630498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effects of mechanical strain on osteoclastogenesis and osteoclast-related gene expression in RAW264.7 cells.
    Xu XY; Guo C; Yan YX; Guo Y; Li RX; Song M; Zhang XZ
    Mol Med Rep; 2012 Aug; 6(2):409-15. PubMed ID: 22580758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Technetium-99 conjugated with methylene diphosphonate inhibits receptor activator of nuclear factor-κB ligand-induced osteoclastogenesis.
    Gong W; Dou H; Liu X; Sun L; Hou Y
    Clin Exp Pharmacol Physiol; 2012 Oct; 39(10):886-93. PubMed ID: 23013134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The inhibitory effect and the molecular mechanism of glabridin on RANKL-induced osteoclastogenesis in RAW264.7 cells.
    Kim HS; Suh KS; Sul D; Kim BJ; Lee SK; Jung WW
    Int J Mol Med; 2012 Feb; 29(2):169-77. PubMed ID: 22038020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostaglandin E₂ increases both osteoblastic and osteoclastic activity in the scales and participates in calcium metabolism in goldfish.
    Omori K; Wada S; Maruyama Y; Hattori A; Kitamura K; Sato Y; Nara M; Funahashi H; Yachiguchi K; Hayakawa K; Endo M; Kusakari R; Yano S; Srivastav AK; Kusui T; Ejiri S; Chen W; Tabuchi Y; Furusawa Y; Kondo T; Sasayama Y; Nishiuchi T; Nakano M; Sakamoto T; Suzuki N
    Zoolog Sci; 2012 Aug; 29(8):499-504. PubMed ID: 22873807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of matrix metalloproteinase-9 activity by doxycycline ameliorates RANK ligand-induced osteoclast differentiation in vitro and in vivo.
    Franco GC; Kajiya M; Nakanishi T; Ohta K; Rosalen PL; Groppo FC; Ernst CW; Boyesen JL; Bartlett JD; Stashenko P; Taubman MA; Kawai T
    Exp Cell Res; 2011 Jun; 317(10):1454-64. PubMed ID: 21420951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of selective cyclooxygenase-2 inhibitor on human osteoclast precursors to influence osteoclastogenesis in vitro.
    Kawashima M; Fujikawa Y; Itonaga I; Takita C; Tsumura H
    Mod Rheumatol; 2009; 19(2):192-8. PubMed ID: 19198759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteoblastogenesis and osteoprotection enhanced by flavonolignan silibinin in osteoblasts and osteoclasts.
    Kim JL; Kang SW; Kang MK; Gong JH; Lee ES; Han SJ; Kang YH
    J Cell Biochem; 2012 Jan; 113(1):247-59. PubMed ID: 21898547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of the bone resorption supernatant from RAW264.7 osteoclast on the osteogenic activity of mouse MC3T3-E1 cell].
    Chen LL; Wang K; Zhang J; Wu YM
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2012 Jan; 47(1):32-7. PubMed ID: 22490219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Yukmijihwang-tang inhibits receptor activator for nuclear Factor-κB ligand-induced osteoclast differentiation.
    Shim KS; Ma CJ; Kim DS; Ma JY
    J Med Food; 2011 Nov; 14(11):1439-47. PubMed ID: 21883017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-17A stimulates granulocyte-macrophage colony-stimulating factor release by murine osteoblasts in the presence of 1,25-dihydroxyvitamin D(3) and inhibits murine osteoclast development in vitro.
    Balani D; Aeberli D; Hofstetter W; Seitz M
    Arthritis Rheum; 2013 Feb; 65(2):436-46. PubMed ID: 23124514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quercetin triggers apoptosis of lipopolysaccharide (LPS)-induced osteoclasts and inhibits bone resorption in RAW264.7 cells.
    Guo C; Hou GQ; Li XD; Xia X; Liu DX; Huang DY; Du SX
    Cell Physiol Biochem; 2012; 30(1):123-36. PubMed ID: 22759961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.